Science ❯Biotechnology

Vaccine Development

Clinical Trials mRNA Technology Infectious Diseases Public Health Research COBRA Method COVID-19 Vaccines Clinical Research Mycobacterium tuberculosis Immunology Innovative Technologies COVID-19 Vaccine Companies DNA-based Vaccines Avian Flu Vaccines Cancer Immunotherapy Innovations in Vaccines Respiratory Syncytial Virus RSV Vaccines

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

The biotech company faces declining demand for its COVID-19 vaccine, a $238M manufacturing charge, and reduced 2025 revenue forecasts.

Georgia Detects First Bird Flu Case in Commercial Poultry Operation

Moderna's mRNA Vaccine Shows Superior Mpox Protection in Animal Studies

Universal Flu Vaccine Candidate Advances Toward Human Trials

Bavarian Nordic Secures Major Contract for Smallpox and Mpox Vaccines

Bird Flu Detected in U.S. Dairy Cows and Pasteurized Milk, Prompting Surveillance Concerns

New Study Reveals Increased Health Risks Linked to COVID-19 Vaccines

FDA Approves Pfizer's RSV Vaccine for Seniors After Success in Late-Stage Trials